{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SVA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T20:20:35.398Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":142,"canonical_name":"SINOVAC BIOTECH LTD","cik":"0001084201","uei":null,"lei":null,"duns":null,"ticker":"SVA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"clinical":6,"sec":7},"count":13,"timeline":[{"ts":"2026-10-02","kind":"clinical.trial","reporter":"Sinovac Biotech Co., Ltd","title":"A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine","security_title":null,"status":"COMPLETED","accession_number":"NCT07855705","excerpt":"[\"Hepatitis A\"]","importance":25},{"ts":"2026-09-23","kind":"clinical.trial","reporter":"Sinovac Biotech Co., Ltd","title":"Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)","security_title":"PHASE1","status":"COMPLETED","accession_number":"NCT07737106","excerpt":"[\"Influenza\"]","importance":30},{"ts":"2026-09-21","kind":"clinical.trial","reporter":"Sinovac Biotech Co., Ltd","title":"A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)","security_title":"PHASE4","status":"NOT_YET_RECRUITING","accession_number":"NCT07832201","excerpt":"[\"Influenza\"]","importance":25},{"ts":"2026-09-01","kind":"clinical.trial","reporter":"Sinovac Biotech Co., Ltd","title":"Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children","security_title":"NA","status":"NOT_YET_RECRUITING","accession_number":"NCT07793175","excerpt":"[\"Hand, Foot, and Mouth Disease (HFMD)\",\"Enterovirus 71 Infection\"]","importance":25},{"ts":"2026-08-28","kind":"clinical.trial","reporter":"Sinovac Biotech Co., Ltd","title":"Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07793227","excerpt":"[\"Hepatitis A Vaccine\"]","importance":60},{"ts":"2026-08-17","kind":"sec.filing","form_type":"6-K","title":"6-K — SINOVAC BIOTECH LTD — 2026-08-17","url_slug":"/sec/cik-0001084201/6-k/0001193125-26-353263","accession_number":"0001193125-26-353263","importance":30},{"ts":"2026-07-15","kind":"sec.filing","form_type":"6-K","title":"6-K — SINOVAC BIOTECH LTD — 2026-07-15","url_slug":"/sec/cik-0001084201/6-k/0001213900-26-078116","accession_number":"0001213900-26-078116","importance":30},{"ts":"2026-06-15","kind":"sec.filing","form_type":"6-K","title":"6-K — SINOVAC BIOTECH LTD — 2026-06-15","url_slug":"/sec/cik-0001084201/6-k/0001213900-26-068483","accession_number":"0001213900-26-068483","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"20-F","title":"20-F — SINOVAC BIOTECH LTD — 2026-06-05","url_slug":"/sec/cik-0001084201/20-f/0001193125-26-258534","accession_number":"0001193125-26-258534","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"6-K","title":"6-K — SINOVAC BIOTECH LTD — 2026-06-05","url_slug":"/sec/cik-0001084201/6-k/0001213900-26-065846","accession_number":"0001213900-26-065846","importance":30},{"ts":"2026-05-28","kind":"clinical.trial","reporter":"Sinovac Biotech Co., Ltd","title":"Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).","security_title":"PHASE3","status":"NOT_YET_RECRUITING","accession_number":"NCT07611513","excerpt":"[\"Hand, Foot, and Mouth Disease(HFMD)\",\"Herpangina\"]","importance":60},{"ts":"2026-05-21","kind":"sec.filing","form_type":"6-K","title":"6-K — SINOVAC BIOTECH LTD — 2026-05-21","url_slug":"/sec/cik-0001084201/6-k/0001213900-26-059828","accession_number":"0001213900-26-059828","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"6-K","title":"6-K — SINOVAC BIOTECH LTD — 2026-05-08","url_slug":"/sec/cik-0001084201/6-k/0001213900-26-054027","accession_number":"0001213900-26-054027","importance":30}]}